Q1 EPS Estimates for Astera Labs Increased by Analyst

Astera Labs, Inc. (NASDAQ:ALAB) – Investment analysts at Northland Securities increased their Q1 2026 earnings per share (EPS) estimates for Astera Labs in a report released on Wednesday, February 11th. Northland Securities analyst G. Richard now anticipates that the company will earn $0.32 per share for the quarter, up from their previous forecast of $0.24. Northland Securities currently has a “Outperform” rating and a $195.00 target price on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $0.34 per share. Northland Securities also issued estimates for Astera Labs’ Q2 2026 earnings at $0.33 EPS, Q3 2026 earnings at $0.35 EPS, Q4 2026 earnings at $0.35 EPS, FY2026 earnings at $1.35 EPS, Q1 2027 earnings at $0.38 EPS and FY2027 earnings at $2.11 EPS.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS.

Other research analysts also recently issued research reports about the stock. Citigroup decreased their target price on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. BNP Paribas Exane began coverage on Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating for the company. Needham & Company LLC lifted their target price on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. JPMorgan Chase & Co. increased their price target on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Roth Mkm boosted their price target on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $192.89.

Astera Labs Stock Up 2.2%

Shares of ALAB opened at $129.32 on Monday. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a market capitalization of $21.84 billion, a P/E ratio of 106.00, a P/E/G ratio of 2.54 and a beta of 1.51. The company has a 50 day moving average of $163.16 and a 200-day moving average of $174.78.

Hedge Funds Weigh In On Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Lido Advisors LLC boosted its stake in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the period. Perigon Wealth Management LLC boosted its position in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after acquiring an additional 73 shares during the period. Clearstead Advisors LLC grew its stake in shares of Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after acquiring an additional 76 shares in the last quarter. Sound Income Strategies LLC raised its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 150,000 shares of the stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total value of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 12.50% of the stock is owned by insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.